Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122900 · ClinicalTrials.gov registry record
Prospective Balloon Aortic Valvuloplasty
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 100
- Enrollment target
NCT02122900 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 100 participants.
The verdict
NCT02122900 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the reasons for balloon aortic valvuloplasty (BAV) in the current clinical setting and to determine the outcomes of BAV in patients with aortic stenosis. The ultimate aim is to establish the safety, effectiveness, and appropriate role of BAV therapy as definitive therapy (palliation) or as a "bridge" to surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02122900
The ClinicalTrials.gov registry entry for NCT02122900 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02122900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02122900 about?
NCT02122900 is a clinical study titled "Prospective Balloon Aortic Valvuloplasty". The primary objective of this study is to determine the reasons for balloon aortic valvuloplasty (BAV) in the current clinical setting and to determine the outcomes of BAV in patients with aortic stenosis. The ultimate aim is to establish the safety, effectiveness, and appropriate role of BAV therap...
What is the current status of trial NCT02122900?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-06. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02122900?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.